Care and use manual, Ii. column use – Waters Oligonucleotide Separation Technology ACQUITY UPLC C18 Columns User Manual

Page 3

Advertising
background image

[ Care and Use ManUal ]

3

ACQUITY UPLC OST C18 column performance can be tested with
the MassPREP OST Standard (P/N 186004135), a quality controlled
synthetic oligonucleotide sample consisting of 15, 20, 25, 30 and
35 mer deoxythymidine. Approximately 0.1 nmol of each oligo-
nucleotide was injected onto the ACQUITY UPLC OST C18 column.
Refer to P/N 715001677 for more information on sample prep for
the MassPREP OST Standard. Smaller peaks eluting prior to the main
peaks are failure, by-product sequences from the synthesis.

Figure 1: Separation using the MassPREP OST Standard on ACQUITY
UPLC OST C18

UPLC

®

System: Waters ACQUITY UPLC

®

System with installed 425 µL mixer

(see Section II, g), PDA Detector with standard UV cell

Sample Injected: Approximately 0.1 nmol of MassPREP OST Standard (P/N 186004135)

diluted in 0.1 M TEAA

Column:

Waters ACQUITY UPLC

®

OST C

18

column, 1.7µm (2.1 x 50 mm)

Mobile Phases: A: 0.1 M TEAA,

B: Acetonitrile / 0.1M TEAA, 20/80, v/v

Flow rate:

0.2 mL/min

Column Temp.: 60 ˚C

Gradient delay: 0.45 mL

Gradient:

40 to 59.5% B in 26 minutes (8-11.9% acetonitrile,

0.15% acetonitrile per minute)

Detection:

260 nm, 5 scans per second

II. Column uSe

To ensure the continued high performance of your ACQUITY UPLC

®

OST C

18

columns, follow these guidelines:

a. Sample preparation
1. Dissolve the detritylated synthetic oligonucleotide sample in

Mobile Phase A (e.g., 0.1 M TEAA). For example, a 0.05 - 0.2 µmole

scale synthesis can be prepared in 0.1 mL of 0.1 M TEAA.

Proportionately larger or smaller volumes of 0.1M TEAA is required

when dissolving samples from different scale syntheses. Due to

the nature of gradient separations, relatively large volumes of sample

(in low organic strength eluent) can be injected and concentrated onto

the head of the column before beginning the gradient elution program.

2. Samples must be completely in solution and free of

particulates. Remove all particles from the sample

(Controlled Pore Glass Synthesis Support, etc.), which may

block the inlet column frit, increase the operating pressure,

and shorten the column life time. Sample contamination with

high concentration of salts and/or detergents may also interfere

with analysis.

3. To remove particulates the sample may be filtered with a

0.2 μm membrane. Be sure that the selected membrane is

compatible and does not dissolve with the selected mobile

phase diluent. Contact the membrane manufacturer with

solvent compatibility questions. An alternative method of

particulate removal involves centrifugation for 20 minutes

at 8,000 rpm, followed by the transfer of the supernatant liquid

to an appropriate vial.

b. recommended mobile phases
The most common ion-pair mobile phase for synthetic oligonucle-
otide separations is based on Triethylammonium Acetate (TEAA).
This mobile phase can be prepared by titrating Glacial Acetic Acid
aqueous solution with Triethylamine (TEA).

Note: To maximize column life, it is ESSENTIAL that all prepared OST
mobile phases be filtered through a solvent compatible, 0.2 µm mem-
brane and contained in bottles that are clean and particulate free.

teaa
1 L of 0.1 M TEAA may be prepared as follows:

1) Perform work in a hood.

0 minutes 28

15

20 25

30

35

Advertising